Breaking the sound barrier: global monoclonal antibody pharmacoequity - Top-Institutions - MDSpire

Breaking the sound barrier: global monoclonal antibody pharmacoequity

  • By

  • Huub C. Gelderblom

  • Glenda Gray

  • Brian Kelley

  • June 23, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Hematology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology

  • #4

    City of Hope
    City of Hope

    Duarte, CA

    Key Differentiators

    • Hematology
    • Oncology

  • #5

    Multiple Myeloma Research Foundation
    Multiple Myeloma Research Foundation

    Norwalk, CT

    Key Differentiators

    • Hematology

Original Source(s)

Breaking the sound barrier: global monoclonal antibody pharmacoequity

  • by Huub C. Gelderblom, Glenda Gray, Brian Kelley

  • June 23, 2026

Related Content

Comparative assessment of tissue cross-reactivity and pharmacokinetic half-life of malaria monoclonal antibodies

A visualization analysis of Traditional Chinese Medicine for influenza prevention and treatment: advances, hotspots, and future trends

Timing and microbiological profile influence long-term outcomes after debridement, antibiotics, and implant retention (DAIR) in acute hip periprosthetic joint infection